Identification	O
of	O
Smoking	O
-	O
Associated	O
Differentially	O
Methylated	O
Regions	O
Using	O
Reduced	O
Representation	O
Bisulfite	O
Sequencing	O
and	O
Cell	O
type	O
-	O
Specific	O
Enhancer	O
Activation	O
and	O
Gene	O
Expression	O
.	O


BACKGROUND	O
:	O
Cigarette	O
smoke	O
is	O
a	O
causal	O
factor	O
in	O
cancers	O
and	O
cardiovascular	O
disease	O
.	O


Smoking	O
-	O
associated	O
differentially	O
methylated	O
regions	O
(	O
SM	O
-	O
DMRs	O
)	O
have	O
been	O
observed	O
in	O
disease	O
studies	O
,	O
but	O
the	O
causal	O
link	O
between	O
altered	O
DNA	O
methylation	O
and	O
transcriptional	O
change	O
is	O
obscure	O
.	O


OBJECTIVE	O
:	O
Our	O
objectives	O
were	O
to	O
finely	O
resolve	O
SM	O
-	O
DMRs	O
and	O
to	O
interrogate	O
the	O
mechanistic	O
link	O
between	O
SM	O
-	O
DMRs	O
and	O
altered	O
transcription	O
of	O
enhancer	O
noncoding	O
RNA	O
(	O
eRNA	O
)	O
and	O
mRNA	O
in	O
human	O
circulating	O
monocytes	O
.	O


METHOD	O
:	O
We	O
integrated	O
SM	O
-	O
DMRs	O
identified	O
by	O
reduced	O
representation	O
bisulfite	O
sequencing	O
(	O
RRBS	O
)	O
of	O
circulating	O
CD14	O
+	O
monocyte	O
DNA	O
collected	O
from	O
two	O
independent	O
human	O
studies	O
[	O
n	O
=	O
38	O
from	O
Clinical	O
Research	O
Unit	O
(	O
CRU	O
)	O
and	O
n	O
=	O
55	O
from	O
the	O
Multi	O
-	O
Ethnic	O
Study	O
of	O
Atherosclerosis	O
(	O
MESA	O
)	O
,	O
about	O
half	O
of	O
whom	O
were	O
active	O
smokers	O
]	O
with	O
gene	O
expression	O
for	O
protein	O
-	O
coding	O
genes	O
and	O
noncoding	O
RNAs	O
measured	O
by	O
RT	O
-	O
PCR	O
or	O
RNA	O
sequencing	O
.	O


Candidate	O
SM	O
-	O
DMRs	O
were	O
compared	O
with	O
RRBS	O
of	O
purified	O
CD4	O
+	O
T	O
cells	O
,	O
CD8	O
+	O
T	O
cells	O
,	O
CD15	O
+	O
granulocytes	O
,	O
CD19	O
+	O
B	O
cells	O
,	O
and	O
CD56	O
+	O
NK	O
cells	O
(	O
n	O
=	O
19	O
females	O
,	O
CRU	O
)	O
.	O


DMRs	O
were	O
validated	O
using	O
pyrosequencing	O
or	O
bisulfite	O
amplicon	O
sequencing	O
in	O
up	O
to	O
85	O
CRU	O
volunteers	O
,	O
who	O
also	O
provided	O
saliva	O
DNA	O
.	O


RESULTS	O
:	O
RRBS	O
identified	O
monocyte	O
SM	O
-	O
DMRs	O
frequently	O
located	O
in	O
putative	O
gene	O
regulatory	O
regions	O
.	O


The	O
most	O
significant	O
monocyte	O
DMR	O
occurred	O
at	O
a	O
poised	O
enhancer	O
in	O
the	O
aryl	B-GENE
-	I-GENE
hydrocarbon	I-GENE
receptor	I-GENE
repressor	E-GENE
gene	O
(	O
AHRR	S-GENE
)	O
and	O
it	O
was	O
also	O
detected	O
in	O
both	O
granulocytes	O
and	O
saliva	O
DNA	O
.	O


To	O
our	O
knowledge	O
,	O
we	O
identify	O
for	O
the	O
first	O
time	O
that	O
SM	O
-	O
DMRs	O
in	O
or	O
near	O
AHRR	S-GENE
,	O
C5orf55	B-GENE
-	I-GENE
EXOC	I-GENE
-	I-GENE
AS	E-GENE
,	O
and	O
SASH1	S-GENE
were	O
associated	O
with	O
increased	O
noncoding	O
eRNA	O
as	O
well	O
as	O
mRNA	O
in	O
monocytes	O
.	O


Functionally	O
,	O
the	O
AHRR	S-GENE
SM	O
-	O
DMR	O
appeared	O
to	O
up	O
-	O
regulate	O
AHRR	S-GENE
mRNA	O
through	O
activating	O
the	O
AHRR	S-GENE
enhancer	O
,	O
as	O
suggested	O
by	O
increased	O
eRNA	O
in	O
the	O
monocytes	O
,	O
but	O
not	O
granulocytes	O
,	O
from	O
smokers	O
compared	O
with	O
nonsmokers	O
.	O


CONCLUSIONS	O
:	O
Our	O
findings	O
suggest	O
that	O
AHRR	S-GENE
SM	O
-	O
DMR	O
up	O
-	O
regulates	O
AHRR	S-GENE
mRNA	O
in	O
a	O
monocyte	O
-	O
specific	O
manner	O
by	O
activating	O
the	O
AHRR	S-GENE
enhancer	O
.	O


Cell	O
type	O
-	O
specific	O
activation	O
of	O
enhancers	O
at	O
SM	O
-	O
DMRs	O
may	O
represent	O
a	O
mechanism	O
driving	O
smoking	O
-	O
related	O
disease	O
.	O
https	O
:	O
/	O
/	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
EHP2395	O
.	O
